Health

In a study of older adults, excessive daytime napping predicted an increased future risk of Alzheimer’s.

Researchers are now looking at a novel therapy for family caregivers that not only reduces depression, but also boosts well-being.

A new target for an old antibiotic is rooted in a decades-long effort to unlock the secrets of a lethal childhood disease.

Harvard’s William Hanage, an epidemiologist and associate professor at the Harvard T.H. Chan School of Public Health, outlines what an endemic SARS-CoV-2 might look like.

Disruptive variants in genes involved in the production of collagen are implicated in spontaneous coronary artery dissection, a major cause of heart attacks in women under 50.

Researchers have learned that nerve damage experienced by some long COVID patients may be caused by infection-triggered immune dysfunction, which is potentially treatable.

A new study in JAMA Internal Medicine makes a strong case that removing cataracts may reduce your risk for developing dementia.

New study reveals that living through the COVID-19 pandemic may trigger brain inflammation that contributes to fatigue, concentration difficulties, and depression.

Colleagues mourn the loss of Paul Farmer, Harvard professor and Partners In Health cofounder, and pledge to continue the work he pioneered.

Across the U.S., prescriptions of hydroxychloroquine and ivermectin increased in the latter part of 2020, most significantly in counties with the highest share of people voting Republican.

Risk assessment experts offer tips for balancing pandemic risks, as government restrictions ease.

As Omicron fades, specialists seek answers for patients who can’t shake symptoms.

Some physicians are far more likely to deliver appropriate care than others in the same geographic area or health care system, according to a new study.

A recent letter addresses the importance of inclusive language in the sciences as part of the ongoing fight for transgender rights

A closer look at the mental health apps that claim to treat depression, anxiety, and other mental illnesses.

“Monoclonal antibodies should first go to patients at the highest risk of death from COVID-19, but the opposite happened …, ” says a Harvard Chan School researcher.

The “milder” outcomes of Omicron are likely due to more population immunity rather than the virus’ properties, according to new research.

Mistrust of vaccine is high among people of color in U.S. and U.K., but unequal access appears to be greater barrier in U.S., researchers say.

In search for alternatives to opioids, Medical School researchers have hit on an unlikely candidate.

A new study finds vitamin D supplements with or without omega-3s decreased the risk of autoimmune diseases by 22 percent compared to placebo.

As Omicron rapidly recedes, some countries are seeing a new version of the variant, dubbed BA.2

A new Harvard study has found that racial, ethnic minorities, and low-income groups in U.S. are exposed to higher levels of air pollution.

One in five youths with substance-use disorders may have undiagnosed autistic traits, say researchers.

Harvard researchers study “super-aging” minds for clues to possible interventions for the rest of us.

A new study finds that women and men physicians participate differently in academic settings, potentially contributing to gender biases that disadvantage female students.

For babies born during this pandemic, a study published in JAMA Pediatrics suggests their brains may not fully develop.

With Omicron on the decline in some states, pandemic experts permit themselves hope, at least for the near term.

Sex differences in COVID death rates vary by state and across time, suggesting social factors play a role.

Researchers detect the COVID-19 variant in the blood and placentas of women who had stillbirths and pregnancy complications.

Harvard Chan School researchers see impact in cardiovascular and respiratory conditions, cancer, and neurodegenerative disease.